Govt Bans Export of Paracetemol, vitamins, and other key drugs, details Medical Dialogues Bureau4 March 2020 11:38 AM ISTThe ban comes into force immediately and will continue till further orders
2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed Medical Dialogues Bureau4 March 2020 10:00 AM ISTFor the induction of antibodies that can neutralize COVID-19, it is essential to use reliable, effective technologies that can be quickly adapted in...
Shortage of generic version of BP drug pindolol, says Sun Pharma Medical Dialogues Bureau3 March 2020 12:36 PM ISTThe coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to...
Ficci calls for preventive measures of coronavirus in India Medical Dialogues Bureau3 March 2020 9:00 AM ISTNew Delhi: Industry body Ficci has recently called for measures to prevent the spread of deadly coronavirus in India, even as two more cases -- one in...
COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE Medical Dialogues Bureau1 March 2020 2:45 PM ISTA manufacturer has alerted that a shortage of a human drug that was recently added to the drug shortages list.
Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear Medical Dialogues Bureau1 March 2020 10:00 AM ISTGermany: Sandoz the provider of off-patent antibiotic medicines worldwide, made a public commitment to ensure stable pricing for a basket of essential...
Mylan warns of possible drug shortages, financial hit due to coronavirus Medical Dialogues Bureau29 Feb 2020 9:30 AM ISTAlthough heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details Medical Dialogues Bureau28 Feb 2020 4:26 PM ISTNew Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01 Medical Dialogues Bureau27 Feb 2020 10:00 AM ISTVienna: APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, has...
COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies Medical Dialogues Bureau27 Feb 2020 9:00 AM ISTWuXi Biologics will conduct cell-line development, process and formulation development, if the antibodies receive regulatory approvals, WuXi Biologics...
Coronavirus: Restrictions imposed on the export of medical equipment to China Medical Dialogues Bureau24 Feb 2020 12:29 PM ISTNew Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
Serum Institute to come up with coronavirus vaccine by 2022 Medical Dialogues Bureau21 Feb 2020 12:13 PM ISTThe vaccine candidate, developed by SII in partnership with American biotechnology firm Codagenix, has progressed to the pre-clinical test phase (the...
